In women at high risk of developing breast cancer, bilateral prophylactic mastectomy (BPM) 1 significantly reduces the risk; simultaneously, breast reconstruction preserves body integrity. Given the complex and personal nature of such surgical procedures, patient assessment of satisfaction and health-related quality of life (HRQoL) 2 is essential in evaluation of surgical outcomes. With this review, we aim to organize the current knowledge on patient-reported outcomes (PROs) 3 in bilateral prophylactic surgery. Literature search was conducted using the databases Google Scholar, PubMed, and Web of Science to address the following questions, which can help clinicians and women undergoing the procedures navigate their healthcare decision-making process: How does BPM with reconstruction influence cancer-related distress? How does the surgery impact patient satisfaction and HRQoL? How do preoperative PROs differ from postoperative outcomes? Does the type of BPM and the type of reconstruction impact patient satisfaction and HRQoL? Furthermore, we summarize available patient-reported outcome measures (PROMs) 4 that can be administered to women undergoing BPM with reconstruction. In addition, we discuss possible future directions for PRO research in prophylactic breast surgery.

Department of Plastic Surgery Kralovske Vinohrady University Hospital and 3rd Faculty of Medicine Charles University Srobarova 50 10034 Praha 10 Czech Republic

Zobrazit více v PubMed

Sakorafas G.H., Tsiotou A.G. Genetic predisposition to breast cancer: a surgical perspective. Br J Surg. 2000;87(2):149–162. doi: 10.1046/j.1365-2168.2000.01347.x. PubMed DOI

Apostolou P., Fostira F. Hereditary breast cancer: the era of new susceptibility genes. BioMed Res Int. 2013:2013. doi: 10.1155/2013/747318. PubMed DOI PMC

Ellisen L.W., Haber D.A. Hereditary breast cancer. Annu Rev Med. 1998;49(1):425–436. doi: 10.1146/annurev.med.49.1.425. PubMed DOI

Wood M.E., McKinnon W., Garber J. Risk for breast cancer and management of unaffected individuals with non‐BRCA hereditary breast cancer. Breast J. 2020;26(8):1528–1534. doi: 10.1111/tbj.13969. PubMed DOI

Hartmann L.C., Schaid D.J., Woods J.E., Crotty T.P., Myers J.L., Arnold P.G., et al. Efficacy of bilateral prophylactic mastectomy in women with a family history of breast cancer. N Engl J Med. 1999;340(2):77–84. doi: 10.1056/NEJM199901143400201. PubMed DOI

Meijers-Heijboer H., van Geel B., van Putten W.L.J., Henzen-Logmans S.C., Seynaeve C., Menke-Pluymers M.B.E., et al. Breast cancer after prophylactic bilateral mastectomy in women with a BRCA1 or BRCA2 mutation. N Engl J Med. 2001;345(3):159–164. doi: 10.1056/NEJM200107193450301. PubMed DOI

Tollow P., Paraskeva N., Clarke A., White P., Powell J., Cox D., et al. ‘They were aware of who I was as a person’: patients' and health professionals' experiences of using the PEGASUS intervention to facilitate decision‐making around breast reconstruction. Eur J Cancer Care. 2021;30(5) doi: 10.1111/ecc.13464. PubMed DOI PMC

Macadam S.A., Zhong T., Weichman K., Papsdorf M., Lennox P.A., Hazen A., et al. Quality of life and patient-reported outcomes in breast cancer survivors: a multi-center comparison of four abdominally-based autologous reconstruction methods. Plast Reconstr Surg. 2016;137(3):758. doi: 10.1097/01.prs.0000479932.11170.8f. PubMed DOI PMC

Jagsi R., Momoh A.O., Qi J., Hamill J.B., Billig J., Kim H.M., et al. Impact of radiotherapy on complications and patient-reported outcomes after breast reconstruction. JNCI: J Natl Cancer Inst. 2018;110(2):157–165. doi: 10.1093/jnci/djx148. PubMed DOI PMC

Flanagan M.R., Zabor E.C., Romanoff A., Fuzesi S., Stempel M., Mehrara B.J., et al. A comparison of patient-reported outcomes after breast-conserving surgery and mastectomy with implant breast reconstruction. Ann Surg Oncol. 2019;26:3133–3140. doi: 10.1245/s10434-019-07548-9. PubMed DOI PMC

Jeevan R., Browne J.P., Gulliver-Clarke C., Pereira J., Caddy C.M., van der Meulen J.H.P., et al. Surgical determinants of patient-reported outcomes following postmastectomy reconstruction in women with breast cancer. Plast Reconstr Surg. 2017;139(5) doi: 10.1097/PRS.0000000000003236. 1036e-45e. PubMed DOI

Pinell-White X.A., Duggal C., Metcalfe D., Sackeyfio R., Hart A.M., Losken A. Patient-reported quality of life after breast reconstruction: a one-year longitudinal study using the WHO-QOL survey. Ann Plast Surg. 2015;75(2):144–148. doi: 10.1097/SAP.0000000000000065. PubMed DOI

Glassey R., Ives A., Saunders C., Musiello T. Decision making, psychological wellbeing and psychosocial outcomes for high risk women who choose to undergo bilateral prophylactic mastectomy–A review of the literature. Breast. 2016;28:130–135. doi: 10.1016/j.breast.2016.05.012. PubMed DOI

Altschuler A., Nekhlyudov L., Rolnick S.J., Greene S.M., Elmore J.G., West C.N., et al. Positive, negative, and disparate—women’s differing long‐term psychosocial experiences of bilateral or contralateral prophylactic mastectomy. Breast J. 2008;14(1):25–32. doi: 10.1111/j.1524-4741.2007.00521.x. PubMed DOI

Frost M.H., Schaid D.J., Sellers T.A., Slezak J.M., Arnold P.G., Woods J.E., et al. Long-term satisfaction and psychological and social function following bilateral prophylactic mastectomy. JAMA. 2000;284(3):319–324. doi: 10.1001/jama.284.3.319. PubMed DOI

Metcalfe K.A., Esplen M.J., Goel V., Narod S.A. Psychosocial functioning in women who have undergone bilateral prophylactic mastectomy. Psycho Oncol: Journal of the Psychological, Social and Behavioral Dimensions of Cancer. 2004;13(1):14–25. doi: 10.1002/pon.726. PubMed DOI

Shiraishi M., Sowa Y., Tsuge I., Kodama T., Inafuku N., Morimoto N. Long-term patient satisfaction and quality of life following breast reconstruction using the BREAST-Q: a prospective cohort study. Front Oncol. 2022;12 doi: 10.3389/fonc.2022.815498. PubMed DOI PMC

Evans D.G., Wisely J., Clancy T., Lalloo F., Wilson M., Johnson R., et al. Longer term effects of the Angelina Jolie effect: increased risk-reducing mastectomy rates in BRCA carriers and other high-risk women. Breast Cancer Res. 2015;17:1–2. doi: 10.1186/s13058-015-0650-8. PubMed DOI PMC

Gierej P., Rajca B., Górecki-Gomoła A. Bilateral risk-reducing mastectomy–surgical procedure, complications and financial benefit. Pol J Surg. 2021;93(3):48–54. doi: 10.5604/01.3001.0014.7878. PubMed DOI

Lynch H.T., Lynch J., Conway T., Watson P., Feunteum J., Lenoir G., et al. Hereditary breast cancer and family cancer syndromes. World J Surg. 1994;18:21–31. doi: 10.1007/BF00348188. PubMed DOI

Lynch B.J., Holden J.A., Buys S.S., Neuhausen S.L., Gaffney D.K. Pathobiologic characteristics of hereditary breast cancer. Hum Pathol. 1998;29(10):1140–1144. doi: 10.1016/s0046-8177(98)90427-0. PubMed DOI

King M.C. Mar s JH, Mandell JB. Breast and ovarian cancer risks due to inherited mutations in BRCA1 and BRCA2 Science. 2003;302:643–646. doi: 10.1126/science.1088759. PubMed DOI

Marcus J.N., Watson P., Page D.L., Narod S.A., Lenoir G.M., Tonin P., et al. Hereditary breast cancer: pathobiology, prognosis, and BRCA1 and BRCA2 gene linkage. Cancer: Interdisciplinary International Journal of the American Cancer Society. 1996;77(4):697–709. doi: 10.1002/(sici)1097-0142(19960215)77:4<697::aid-cncr16>3.0.co;2-w. PubMed DOI

Mahdavi M., Nassiri M., Kooshyar M.M., Vakili‐Azghandi M., Avan A., Sandry R., et al. Hereditary breast cancer; Genetic penetrance and current status with BRCA. J Cell Physiol. 2019;234(5):5741–5750. doi: 10.1002/jcp.27464. PubMed DOI

Paul A., Paul S. The breast cancer susceptibility genes (BRCA) in breast and ovarian cancers. Front Biosci. 2014;19:605. doi: 10.2741/4230. PubMed DOI PMC

Yoshida K., Miki Y. Role of BRCA1 and BRCA2 as regulators of DNA repair, transcription, and cell cycle in response to DNA damage. Cancer Sci. 2004;95(11):866–871. doi: 10.1111/j.1349-7006.2004.tb02195.x. PubMed DOI PMC

Lord C.J., Ashworth A. Mechanisms of resistance to therapies targeting BRCA-mutant cancers. Nat Med. 2013;19(11):1381–1388. doi: 10.1038/nm.3369. PubMed DOI

Narod S.A., Foulkes W.D. BRCA1 and BRCA2: 1994 and beyond. Nat Rev Cancer. 2004;4(9):665–676. doi: 10.1038/nrc1431. PubMed DOI

Yoshida R. Hereditary breast and ovarian cancer (HBOC): review of its molecular characteristics, screening, treatment, and prognosis. Breast Cancer. 2021;28(6):1167–1180. doi: 10.1007/s12282-020-01148-2. PubMed DOI PMC

Petrucelli N., Daly M.B., Pal T. 2022. BRCA1-and BRCA2-associated hereditary breast and ovarian cancer. GeneReviews®[Internet] PubMed

Lee M.V., Katabathina V.S., Bowerson M.L., Mityul M.I., Shetty A.S., Elsayes K.M., et al. BRCA-associated cancers: role of imaging in screening, diagnosis, and management. Radiographics. 2017;37(4):1005–1023. doi: 10.1148/rg.2017160144. PubMed DOI

Kuchenbaecker K.B., Hopper J.L., Barnes D.R., Phillips K.-A., Mooij T.M., Roos-Blom M.-J., et al. Risks of breast, ovarian, and contralateral breast cancer for BRCA1 and BRCA2 mutation carriers. JAMA. 2017;317(23):2402–2416. doi: 10.1001/jama.2017.7112. PubMed DOI

Sepahi I., Faust U., Sturm M., Bosse K., Kehrer M., Heinrich T., et al. Investigating the effects of additional truncating variants in DNA-repair genes on breast cancer risk in BRCA1-positive women. BMC Cancer. 2019;19:1–12. doi: 10.1186/s12885-019-5946-0. PubMed DOI PMC

Van der Groep P., van der Wall E., van Diest P.J. Pathology of hereditary breast cancer. Cell Oncol(Dordr) 2011 doi: 10.1007/s13402-011-0010-3. Apr. 2011. PubMed DOI PMC

Krontiras H., Farmer M., Whatley J. Breast cancer genetics and indications for prophylactic mastectomy. Surgical Clinics. 2018;98(4):677–685. doi: 10.1016/j.suc.2018.03.004. PubMed DOI

Angeli D., Salvi S., Tedaldi G. Genetic predisposition to breast and ovarian cancers: how many and which genes to test? Int J Mol Sci. 2020;21(3):1128. doi: 10.3390/ijms21031128. PubMed DOI PMC

Huber-Keener K.J. Cancer genetics and breast cancer. Best Pract Res Clin Obstet Gynaecol. 2022 doi: 10.1016/j.bpobgyn.2022.01.007. PubMed DOI

Honold F., Camus Appuhn M.G. 2018. Prophylactic mastectomy versus surveillance for the prevention of breast cancer in women's BRCA carriers. PubMed DOI

Domchek S.M., Friebel T.M., Singer C.F., Evans D.G., Lynch H.T., Isaacs C., et al. Association of risk-reducing surgery in BRCA1 or BRCA2 mutation carriers with cancer risk and mortality. JAMA. 2010;304(9):967–975. doi: 10.1001/jama.2010.1237. PubMed DOI PMC

Clarijs M.E., van Egdom L.S.E., Verhoef C., Vasilic D., Koppert L.B., Group P.C. Protocol: bilateral prophylactic mastectomy: should we preserve the pectoral fascia? Protocol of a Dutch double blinded, prospective, randomised controlled pilot study with a within-subject design (PROFAS) BMJ Open. 2023;13(2) doi: 10.1136/bmjopen-2022-066728. PubMed DOI PMC

Weiss A., Garber J.E., King T. Breast cancer surgical risk reduction for patients with inherited mutations in moderate penetrance genes. JAMA surgery. 2018;153(12):1145–1146. doi: 10.1001/jamasurg.2018.2493. PubMed DOI

Franceschini G., Di Leone A., Terribile D., Sanchez M.A., Masetti R. Bilateral prophylactic mastectomy in BRCA mutation carriers: what surgeons need to know. Ann Ital Chir. 2019;90:1–2. PubMed

Frost M.H., Slezak J.M., Tran N.V., Williams C.I., Johnson J.L., Woods J.E., et al. Satisfaction after contralateral prophylactic mastectomy: the significance of mastectomy type, reconstructive complications, and body appearance. J Clin Oncol. 2005;23(31):7849–7856. doi: 10.1200/JCO.2005.09.233. PubMed DOI

Webb C., Jacox N., Temple-Oberle C. The making of breasts: navigating the symbolism of breasts in women facing cancer. Plastic surgery. 2019;27(1):49–53. doi: 10.1177/2292550318800500. PubMed DOI PMC

Stefanek M., Enger C., Benkendorf J., Honig S.F., Lerman C. Bilateral prophylactic mastectomy decision making: a vignette study. Prev Med. 1999;29(3):216–221. doi: 10.1006/pmed.1999.0524. PubMed DOI

Catana A., Apostu A.P., Antemie R.-G. Multi gene panel testing for hereditary breast cancer-is it ready to be used? Medicine and Pharmacy Reports. 2019;92(3):220. doi: 10.15386/mpr-1083. PubMed DOI PMC

Berger E.R., Golshan M. Surgical management of hereditary breast cancer. Genes. 2021;12(9):1371. doi: 10.3390/genes12091371. PubMed DOI PMC

Alaofi R.K., Nassif M.O., Al-Hajeili M.R. Prophylactic mastectomy for the prevention of breast cancer: review of the literature. Avicenna journal of medicine. 2018;8(3):67–77. doi: 10.4103/ajm.AJM_21_18. PubMed DOI PMC

Meadows K.A. Patient-reported outcome measures: an overview. Br J Community Nurs. 2011;16(3):146–151. doi: 10.12968/bjcn.2011.16.3.146. PubMed DOI

Noonan V.K., Lyddiatt A., Ware P., Jaglal S.B., Riopelle R.J., Bingham C.O., Iii, et al. Montreal Accord on Patient-Reported Outcomes (PROs) use series–Paper 3: patient-reported outcomes can facilitate shared decision-making and guide self-management. J Clin Epidemiol. 2017;89:125–135. doi: 10.1016/j.jclinepi.2017.04.017. PubMed DOI

St-Pierre D., Bouchard K., Gauthier L., Chiquette J., Dorval M., Centre R. Perspectives of women considering bilateral prophylactic mastectomy and their peers towards a telephone-based peer support intervention. J Genet Counsel. 2018;27:274–288. doi: 10.1007/s10897-017-0148-x. PubMed DOI

Deshpande P.R., Rajan S., Sudeepthi B.L., Nazir C.P.A. Patient-reported outcomes: a new era in clinical research. Perspectives in clinical research. 2011;2(4):137. doi: 10.4103/2229-3485.86879. PubMed DOI PMC

Calvert M., Kyte D., Price G., Valderas J.M., Hjollund N.H. Maximising the impact of patient reported outcome assessment for patients and society. Bmj. 2019;364 doi: 10.4103/2229-3485.86879. PubMed DOI

Wasteson E., Sandelin K., Brandberg Y., Wickman M., Arver B. High satisfaction rate ten years after bilateral prophylactic mastectomy–a longitudinal study. Eur J Cancer Care. 2011;20(4):508–513. doi: 10.1111/j.1365-2354.2010.01204.x. PubMed DOI

Glassey R., O'Connor M., Ives A., Saunders C., Hardcastle S.J., kConFab I. Influences on satisfaction with reconstructed breasts and intimacy in younger women following bilateral prophylactic mastectomy: a qualitative analysis. Int J Behav Med. 2018;25:390–398. doi: 10.1007/s12529-018-9722-3. PubMed DOI

Josephson U., Wickman M., Sandelin K. Initial experiences of women from hereditary breast cancer families after bilateral prophylactic mastectomy: a retrospective study. Eur J Surg Oncol. 2000;26(4):351–356. doi: 10.1053/ejso.1999.0897. PubMed DOI

Carrozzino D., Patierno C., Guidi J., Berrocal Montiel C., Cao J., Charlson M.E., et al. Clinimetric criteria for patient-reported outcome measures. Psychother Psychosom. 2021;90(4):222–232. doi: 10.1159/000516599. PubMed DOI

Pusic A.L., Klassen A.F., Scott A.M., Klok J.A., Cordeiro P.G., Cano S.J. Development of a new patient-reported outcome measure for breast surgery: the BREAST-Q. Plast Reconstr Surg. 2009;124(2):345–353. doi: 10.1097/PRS.0b013e3181aee807. PubMed DOI

Mokkink L.B., Terwee C.B., Knol D.L., Stratford P.W., Alonso J., Patrick D.L., et al. The COSMIN checklist for evaluating the methodological quality of studies on measurement properties: a clarification of its content. BMC Med Res Methodol. 2010;10(1):1–8. doi: 10.1186/1471-2288-10-22. PubMed DOI PMC

Cella D., Hahn E.A., Jensen S.E., Butt Z., Nowinski C.J., Rothrock N., et al. 2015. Patient-reported outcomes in performance measurement. PubMed DOI

Barelds D.P.H., Luteijn F., Arrindell W.A. Swets Test Publishers; Lisse: 2003. NRV-nederlandse relatie vragenlijst-handleiding.

Gopie J.P., Mureau M.A.M., Seynaeve C., Ter Kuile M.M., Menke-Pluymers M.B.E., Timman R., et al. Body image issues after bilateral prophylactic mastectomy with breast reconstruction in healthy women at risk for hereditary breast cancer. Fam Cancer. 2013;12:479–487. doi: 10.1007/s10689-012-9588-5. PubMed DOI

Tavakol M., Dennick R. Making sense of Cronbach's alpha. Int J Med Educ. 2011;2:53. PubMed PMC

Klassen A.F., Cano S.J., Alderman A., Soldin M., Thoma A., Robson S., et al. The BODY-Q: a patient-reported outcome instrument for weight loss and body contouring treatments. Plastic and reconstructive surgery Global open. 2016;4(4) doi: 10.1097/GOX.0000000000000665. PubMed DOI PMC

Hopwood P., Fletcher I., Lee A., Al Ghazal S. A body image scale for use with cancer patients. Eur J Cancer. 2001;37(2):189–197. doi: 10.1016/s0959-8049(00)00353-1. PubMed DOI

Brehaut J.C., O'Connor A.M., Wood T.J., Hack T.F., Siminoff L., Gordon E., et al. Validation of a decision regret scale. Med Decis Making. 2003;23(4):281–292. doi: 10.1177/0272989X03256005. PubMed DOI

Spitzer R.L., Kroenke K., Williams J.B.W., Löwe B. A brief measure for assessing generalized anxiety disorder: the GAD-7. Arch Intern Med. 2006;166(10):1092–1097. doi: 10.1001/archinte.166.10.1092. PubMed DOI

Mossman S.A., Luft M.J., Schroeder H.K., Varney S.T., Fleck D.E., Barzman D.H., et al. The Generalized Anxiety Disorder 7-item (GAD-7) scale in adolescents with generalized anxiety disorder: signal detection and validation. Ann Clin Psychiatr: official journal of the American Academy of Clinical Psychiatrists. 2017;29(4):227. PubMed PMC

Johnson S.U., Ulvenes P.G., Øktedalen T., Hoffart A. Psychometric properties of the general anxiety disorder 7-item (GAD-7) scale in a heterogeneous psychiatric sample. Front Psychol. 2019;10:1713. doi: 10.3389/fpsyg.2019.01713. PubMed DOI PMC

Zigmond A.S., Snaith R.P. The hospital anxiety and depression scale. Acta Psychiatr Scand. 1983;67(6):361–370. doi: 10.1111/j.1600-0447.1983.tb09716.x. PubMed DOI

Mykletun A., Stordal E., Dahl A.A. Hospital Anxiety and Depression (HAD) scale: factor structure, item analyses and internal consistency in a large population. Br J Psychiatr. 2001;179(6):540–544. doi: 10.1192/bjp.179.6.540. PubMed DOI

Beck J.G., Grant D.M., Read J.P., Clapp J.D., Coffey S.F., Miller L.M., et al. The impact of event scale-revised: psychometric properties in a sample of motor vehicle accident survivors. J Anxiety Disord. 2008;22(2):187–198. doi: 10.1016/j.janxdis.2007.02.007. PubMed DOI PMC

Salsman J.M., Schalet B.D., Andrykowski M.A., Cella D. The impact of events scale: a comparison of frequency versus severity approaches to measuring cancer‐specific distress. Psycho Oncol. 2015;24(12):1738–1745. doi: 10.1002/pon.3784. PubMed DOI PMC

Horowitz M., Wilner N., Alvarez W. Impact of Event Scale: a measure of subjective stress. Psychosom Med. 1979;41(3):209–218. doi: 10.1097/00006842-197905000-00004. PubMed DOI

Echevarria‐Guanilo M.E., Dantas R.A.S., Farina J.A., Jr., Alonso J., Rajmil L., Rossi L.A. Reliability and validity of the Impact of Event Scale (IES): version for Brazilian burn victims. J Clin Nurs. 2011;20(11‐12):1588–1597. doi: 10.1111/j.1365-2702.2010.03607.x. PubMed DOI

Kroenke K., Spitzer R.L., Williams J.B.W. The PHQ‐9: validity of a brief depression severity measure. J Gen Intern Med. 2001;16(9):606–613. doi: 10.1046/j.1525-1497.2001.016009606.x. PubMed DOI PMC

Maroufizadeh S., Omani-Samani R., Almasi-Hashiani A., Amini P., Sepidarkish M. The reliability and validity of the Patient Health Questionnaire-9 (PHQ-9) and PHQ-2 in patients with infertility. Reprod Health. 2019;16(1):1–8. doi: 10.1186/s12978-019-0802-x. PubMed DOI PMC

Evans J.P., Smith A., Gibbons C., Alonso J., Valderas J.M. The National Institutes of Health patient-reported outcomes measurement information system (PROMIS): a view from the UK. Patient Relat Outcome Meas. 2018:345–352. doi: 10.2147/PROM.S141378. PubMed DOI PMC

Hays R.D., Spritzer K.L., Schalet B.D., Cella D. PROMIS®-29 v2. 0 profile physical and mental health summary scores. Qual Life Res. 2018;27:1885–1891. doi: 10.1007/s11136-018-1842-3. PubMed DOI PMC

Elsman E.B.M., Roorda L.D., Smidt N., de Vet H.C.W., Terwee C.B. Measurement properties of the Dutch PROMIS-29 v2. 1 profile in people with and without chronic conditions. Qual Life Res. 2022;31(12):3447–3458. doi: 10.1007/s11136-022-03171-6. PubMed DOI PMC

Holmes-Rovner M., Kroll J., Schmitt N., Rovner D.R., Breer M.L., Rothert M.L., et al. Patient satisfaction with health care decisions: the satisfaction with decision scale. Med Decis Making. 1996;16(1):58–64. doi: 10.1177/0272989X9601600114. PubMed DOI

Thirlaway K., Fallowfield L., Cuzick J. The Sexual Activity Questionnaire: a measure of women's sexual functioning. Qual Life Res. 1996;5:81–90. doi: 10.1007/BF00435972. PubMed DOI

da Costa F.A., Ribeiro M.C., Braga S., Carvalho E., Francisco F., da Costa Miranda A., et al. Sexual dysfunction in breast cancer survivors: cross-cultural adaptation of the Sexual Activity Questionnaire for use in Portugal. Acta Med Port. 2016;29(9):533–541. doi: 10.20344/amp.7389. PubMed DOI

Melzack R. The short-form McGill pain questionnaire. Pain. 1987;30(2):191–197. doi: 10.1016/0304-3959(87)91074-8. PubMed DOI

Alharbi H.A., Albabtain M.A., Alobiad N., Alhasan J.A., Alruhaimi M., Alnefisah M., et al. Pain perception assessment using the short-form McGill pain questionnaire after cardiac surgery. Saudi J Anaesth. 2020;14(3):343. doi: 10.4103/sja.SJA_34_20. PubMed DOI PMC

Truong P.T., Abnousi F., Yong C.M., Hayashi A., Runkel J.A., Phillips T., et al. Standardized assessment of breast cancer surgical scars integrating the Vancouver Scar Scale, Short-Form McGill Pain Questionnaire, and patients' perspectives. Plast Reconstr Surg. 2005;116(5):1291–1299. doi: 10.1097/01.prs.0000181520.87883.94. PubMed DOI

Ware J.E., Jr. SF-36 health survey update. Spine. 2000;25(24):3130–3139. doi: 10.1097/00007632-200012150-00008. PubMed DOI

Ware J.E., Jr., Sherbourne C.D. The MOS 36-item short-form health survey (SF-36): I. Conceptual framework and item selection. Med Care. 1992:473–483. PubMed

Bunevicius A. Reliability and validity of the SF-36 Health Survey Questionnaire in patients with brain tumors: a cross-sectional study. Health Qual Life Outcome. 2017;15:1–7. doi: 10.1186/s12955-017-0665-1. PubMed DOI PMC

García-Solbas S., Lorenzo-Liñán M.Á., Castro-Luna G. Long-term quality of life (BREAST-Q) in patients with mastectomy and breast reconstruction. Int J Environ Res Publ Health. 2021;18(18):9707. doi: 10.3390/ijerph18189707. PubMed DOI PMC

Cano S.J., Klassen A.F., Scott A.M., Pusic A.L. A closer look at the BREAST-Q. Clin Plast Surg. 2013;40(2):287–296. doi: 10.1016/j.cps.2012.12.002. PubMed DOI

Liu T., Freijs C., Klein H.J., Feinbaum A., Svee A., Lorenzo A.R., et al. Patients with abdominal-based free flap breast reconstruction a decade after surgery: a comprehensive long-term follow-up study. J Plast Reconstr Aesthetic Surg. 2018;71(9):1301–1309. doi: 10.1016/j.bjps.2018.06.009. PubMed DOI

McCarthy C.M., Hamill J.B., Kim H.M., Qi J., Wilkins E., Pusic A.L. Impact of bilateral prophylactic mastectomy and immediate reconstruction on health-related quality of life in women at high risk for breast carcinoma: results of the mastectomy reconstruction outcomes consortium study. Ann Surg Oncol. 2017;24:2502–2508. doi: 10.1245/s10434-017-5915-2. PubMed DOI PMC

Brandberg Y., Sandelin K., Erikson S., Jurell Gr, Liljegren A., Lindblom A., et al. Psychological reactions, quality of life, and body image after bilateral prophylactic mastectomy in women at high risk for breast cancer: a prospective 1-year follow-up study. J Clin Oncol. 2008;26(24):3943–3949. doi: 10.1200/JCO.2007.13.9568. PubMed DOI

Gahm J., Wickman M., Brandberg Y. Bilateral prophylactic mastectomy in women with inherited risk of breast cancer–prevalence of pain and discomfort, impact on sexuality, quality of life and feelings of regret two years after surgery. Breast. 2010;19(6):462–469. doi: 10.1016/j.breast.2010.05.003. PubMed DOI

Metcalfe K.A., Cil T.D., Semple J.L., Li L.D.X., Bagher S., Zhong T., et al. Long-term psychosocial functioning in women with bilateral prophylactic mastectomy: does preservation of the nipple-areolar complex make a difference? Ann Surg Oncol. 2015;22:3324–3330. doi: 10.1245/s10434-015-4761-3. PubMed DOI

Metcalfe K.A., Semple J.L., Narod S.A. Satisfaction with breast reconstruction in women with bilateral prophylactic mastectomy: a descriptive study. Plast Reconstr Surg. 2004;114(2):360–366. doi: 10.1097/01.prs.0000131877.52740.0e. PubMed DOI

Dysvik E., Lindstrøm T.C., Eikeland O.-J., Natvig G.K. Health-related quality of life and pain beliefs among people suffering from chronic pain. Pain Manag Nurs. 2004;5(2):66–74. doi: 10.1016/j.pmn.2003.11.003. PubMed DOI

Hickey O.T., Nugent N.F., Burke S.M., Hafeez P., Mudrakouski A.L., Shorten G.D. Persistent pain after mastectomy with reconstruction. J Clin Anesth. 2011;23(6):482–488. doi: 10.1016/j.jclinane.2011.01.009. PubMed DOI

Smith W.C.S., Bourne D., Squair J., Phillips D.O., Chambers W.A. A retrospective cohort study of post mastectomy pain syndrome. Pain. 1999;83(1):91–95. doi: 10.1016/s0304-3959(99)00076-7. PubMed DOI

Krøner K., Krebs B., Skov J., Jørgensen H.S. Immediate and long-term phantom breast syndrome after mastectomy: incidence, clinical characteristics and relationship to pre-mastectomy breast pain. Pain. 1989;36(3):327–334. doi: 10.1016/0304-3959(89)90092-4. PubMed DOI

Wallace M.S., Wallace A.M., Lee J., Dobke M.K. Pain after breast surgery: a survey of 282 women. PAIN®. 1996;66(2–3):195–205. doi: 10.1016/0304-3959(96)03064-3. PubMed DOI

Spindler N., Ebel F., Briest S., Wallochny S., Langer S. Quality of life after bilateral risk-reducing mastectomy and simultaneous reconstruction using pre-pectoral silicone implants. Patient Prefer Adherence. 2021:741–750. doi: 10.2147/PPA.S303208. PubMed DOI PMC

Mira J.J., Tomás O., Virtudes-Pérez M., Nebot C., Rodríguez-Marín J. Predictors of patient satisfaction in surgery. Surgery. 2009;145(5):536–541. doi: 10.1016/j.surg.2009.01.012. PubMed DOI

Jakub J.W., Peled A.W., Gray R.J., Greenup R.A., Kiluk J.V., Sacchini V., et al. Oncologic safety of prophylactic nipple-sparing mastectomy in a population with BRCA mutations: a multi-institutional study. JAMA surgery. 2018;153(2):123–129. doi: 10.1001/jamasurg.2017.3422. PubMed DOI PMC

Co M., Chiu R., Chiu T.M., Chong Y.C., Lau S., Lee Y.H., et al. Nipple-sparing mastectomy and its application on BRCA gene mutation carrier. Clin Breast Cancer. 2017;17(8):581–584. doi: 10.1016/j.clbc.2017.02.001. PubMed DOI

Muller T., Baratte A., Bruant-Rodier C., Bodin F., Mathelin C., editors. Oncological safety of nipple-sparing prophylactic mastectomy: a review of the literature on 3716 cases. Elsevier; 2018. PubMed DOI

van Verschuer V.M.T., Maijers M.C., van Deurzen C.H.M., Koppert L.B. Oncological safety of prophylactic breast surgery: skin-sparing and nipple-sparing versus total mastectomy. Gland Surg. 2015;4(6):467. doi: 10.3978/j.issn.2227-684X.2015.02.01. PubMed DOI PMC

O'Connell R.L., Tasoulis M.K., Hristova E., Teoh V., Agusti A., Ward A., et al. Satisfaction with long-term aesthetic and 10 Years oncologic outcome following risk-reducing mastectomy and implant-based breast reconstruction with or without nipple preservation. Cancers. 2022;14(15):3607. doi: 10.3390/cancers14153607. PubMed DOI PMC

van Verschuer V.M.T., Mureau M.A.M., Gopie J.P., Vos E.L., Verhoef C., Menke-Pluijmers M.B.E., et al. Patient satisfaction and nipple-areola sensitivity after bilateral prophylactic mastectomy and immediate implant breast reconstruction in a high breast cancer risk population: nipple-sparing mastectomy versus skin-sparing mastectomy. Ann Plast Surg. 2016;77(2):145–152. doi: 10.1097/SAP.0000000000000366. PubMed DOI

Salibian A.A., Bekisz J.M., Frey J.D., Miller B., Choi M., Karp N.S. Prophylactic nipple‐sparing mastectomy in young previvors: examining decision‐making, reconstructive outcomes, and patient satisfaction in BRCA+ patients under 30. Breast J. 2020;26(5):971–975. doi: 10.1111/tbj.13692. PubMed DOI

Toyserkani N.M., Jørgensen M.G., Tabatabaeifar S., Damsgaard T., Sørensen J.A. Autologous versus implant-based breast reconstruction: a systematic review and meta-analysis of Breast-Q patient-reported outcomes. J Plast Reconstr Aesthetic Surg. 2020;73(2):278–285. doi: 10.1016/j.bjps.2019.09.040. PubMed DOI

Miseré R.M.L., Joosen M.E.M., Claassens E.L., de Grzymala A.A.P., Heuts E.M., van der Hulst R.R.W.J. Patient-reported outcomes following bilateral prophylactic mastectomy and immediate breast reconstruction: comparing implant-based with autologous breast reconstruction. Eur J Plast Surg. 2022;45(5):763–769. doi: 10.1007/s00238-022-01950-5. DOI

Gahm J., Edsander-Nord Å., Jurell G., Wickman M. No differences in aesthetic outcome or patient satisfaction between anatomically shaped and round expandable implants in bilateral breast reconstructions: a randomized study. Plast Reconstr Surg. 2010;126(5):1419–1427. doi: 10.1097/PRS.0b013e3181ef8b01. PubMed DOI

Maruccia M., Elia R., Tedeschi P., Gurrado A., Moschetta M., Testini M., et al. Prepectoral breast reconstruction: an ideal approach to bilateral risk-reducing mastectomy. Gland Surg. 2021;10(10):2997. doi: 10.21037/gs-21-339. PubMed DOI PMC

Carreira H., Williams R., Dempsey H., Stanway S., Smeeth L., Bhaskaran K. Quality of life and mental health in breast cancer survivors compared with non-cancer controls: a study of patient-reported outcomes in the United Kingdom. J Cancer Survivorship. 2021;15:564–575. doi: 10.1007/s11764-020-00950-3. PubMed DOI PMC

Mundy L.R., Rosenberger L.H., Rushing C.N., Atisha D., Pusic A.L., Hollenbeck S.T., et al. The evolution of breast satisfaction and well-being after breast cancer: a propensity-matched comparison to the norm. Plast Reconstr Surg. 2020;145(3):595. doi: 10.1097/PRS.0000000000006535. PubMed DOI PMC

Koch V.G. Medical decision making and the previvor. J Clin Ethics. 2022;33(2):141–145. PubMed

Gandhi A., Duxbury P., Murphy J., Foden P., Lalloo F., Clancy T., et al. Patient reported outcome measures in a cohort of patients at high risk of breast cancer treated by bilateral risk reducing mastectomy and breast reconstruction. J Plast Reconstr Aesthetic Surg. 2022;75(1):69–76. doi: 10.1016/j.bjps.2021.06.012. PubMed DOI